Status: current, Defined. Date: 31-Aug 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3073861000168111 | Optiray-350 Ultraject (ioversol 741 mg / 1 mL) injection, 1 x 30 mL syringe (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3073871000168117 | Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | Is a | Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | true | Inferred relationship | Some | ||
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has container type | syringe | true | Inferred relationship | Some | ||
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has TP | Optiray-350 Ultraject | true | Inferred relationship | Some | ||
| Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | has TPUU | Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 30 mL syringe | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR